Hugendubel.info - Die B2B Online-Buchhandlung 

Merkliste
Die Merkliste ist leer.
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Cancer Stem Cell Markers and Related Network Pathways

BuchKartoniert, Paperback
156 Seiten
Englisch
Springererschienen am04.01.20241st ed. 2022
This book entitled Cancer Stem Cell Markers and Related Network Path-ways is about cancer stem cell (CSC) markers and the molecular network pathways.mehr
Verfügbare Formate
BuchGebunden
EUR139,09
BuchKartoniert, Paperback
EUR139,09

Produkt

KlappentextThis book entitled Cancer Stem Cell Markers and Related Network Path-ways is about cancer stem cell (CSC) markers and the molecular network pathways.
Details
ISBN/GTIN978-3-031-12976-6
ProduktartBuch
EinbandartKartoniert, Paperback
Verlag
Erscheinungsjahr2024
Erscheinungsdatum04.01.2024
Auflage1st ed. 2022
ReiheAdvances in Experimental Medicine and Biology
Seiten156 Seiten
SpracheEnglisch
IllustrationenXIV, 156 p. 23 illus., 21 illus. in color.
Artikel-Nr.55772229
Rubriken
GenreMedizin

Inhalt/Kritik

Inhaltsverzeichnis
1. Epithelial-mesenchymal transition and cancer stem cells.-  2. The transcription factors Zeb1 and Snail induce cell malignancy and can-cer stem cell phenotype in prostate cells, increasing androgen synthesis ca-pacity and therapy resistance.- 3. ERBB signaling pathway in cancer stem cells.-  4. Functional and molecular characters of cancer stem cells through devel-opment to establishment.- 5. Microenvironment in cancer stem cells.- 6. Cancer stem cells contribute to drug resistance in multiple different ways.- 7. Abnormal glycosylation in cancer cells and cancer stem cells as a thera-peutic target.mehr

Autor

Shihori Tanabe, Ph.D. has been working as a Senior Researcher at the Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences from April 2016. From Apr 2005 until Jan 2006 she held a position of a Post Doctoral Fellow at the Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, The University of Tokyo. From Feb 2006 until Mar 2010 she worked as a Researcher at the Division of Cellular and Gene Therapy Products, National Institute of Health Sciences, Tokyo Japan. She also had a position of a Senior Researcher at the Division of Safety Information on Drug, Food and Chemicals, National Institute of Health Sciences (Apr 2010 - Mar 2016, Tokyo Japan)
Weitere Artikel von
Herausgegeben:Tanabe, Shihori